Our partner is a clinical-stage biopharmaceutical company leading the way in targeted protein degradation therapeutics and is the first company to focus solely on protein degradation and its platform technology is the most advanced in the field.

This critical hire led cross-functional teams to develop integrated plans for pre-clinical and early clinical programs, supporting IND filings and Phase I/II studies. With a focus on oncology and clinical product development, the hire collaborated closely with Research and Clinical teams to ensure timely execution of program objectives. The ideal candidate brought expertise in clinical development strategies and a strong understanding of the pharmaceutical industry.